FDA Update
The U.S. Food and Drug Administration (FDA) has published a presentation on ongoing activities of the FDA. It also intends to show how changes in FDA regulations and actions could affect pharmaceutical industry's practice. The following tasks are covered:
- FDA mission
- Approval and actions
- Drug safety information
- Safe Use Initiative
- REMS/Medication Guides
- Patient Medication Information (PMI)
- Sentinel Initiative
- OTC News
- Recalls
- Drug shortages
- Supply chain integrity
Get more in the presentation "FDA Update".
Related GMP News
17.09.2025When Training Falls Short: FDA Findings on GMP Training Deficiencies in 2025
17.09.2025Dealing with Systems without Audit Trail Functionality
17.09.2025Why is RCA (Root Cause Analysis) so important?
10.09.2025The Use of Hoses in Pharmaceutical Production
10.09.2025Revision of EU-GMP Chapter 1 planned with Consultation Phase
10.09.2025Audit Trail Review by the QP / Dealing with a Lack of Justification